Responses
Research Article
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
Compose a Response to This Article
Other responses
No responses have been published for this article.